Alterations in plasma soluble vascular endothelial growth factor receptor-1 (sFlt-1) concentrations during coronary artery bypass graft surgery: Relationships with post-operative complications

Journal of Cardiothoracic Surgery

Volumn 3, Issue 1, 2008, Pages

  Denizot, Yves ^a   Leguyader, Alexandre ^b   Cornu, Elisabeth ^b   Laskar, Marc ^b   Orsel, Isabelle ^b   Vincent, Christelle ^a   Nathan, Nathalie ^b  

^a UNIVERSITY OF LIMOGES   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLT1 PROTEIN, HUMAN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ARTICLE; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; METHODOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS;

CORONARY ARTERY BYPASS; CORONARY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INCIDENCE; INTRAOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 43149110611     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-3-16     Document Type: Article

References (25)

1. Weigand MA Hörner C Bardenheuer HJ Bouchon A The systemic inflammatory response syndrome Best Pract Res Clin Anaesthesiol 2004, 18:455-475 10.1016/j.bpa.2003.12.005 15212339
2. Paparella D Brister SJ Buchanan MR Coagulation disorders of cardiopulmonary bypass: A review Intensive Care Med 2004, 30(10):1873-1881 10.1007/s00134-004-2388-0 15278267
3. Nathan N Denizot Y Cornu E Jauberteau MO Chauveau C Feiss P Cytokine and lipid mediator blood concentrations after coronary artery surgery Anesth Analg 1997, 85:1240-1246 10.1097/00000539-199712000-00011 9390587
4. Denizot Y Lorgeot V Cornu E Nathan N Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation Cytokine 1998, 10:303-306 10.1006/cyto.1997.0285 9617576
5. Nathan N Preux PM Feiss P Denizot Y Plasma interleukin-4, interleukin-10, and interleukin-13 concentrations and complications after coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 2000, 14:156-160 10.1016/S1053-0770(00)90010-7 10794334
6. Denizot Y Karoutsos S Nathan N Differential alterations in plasma colony-stimulating factor concentrations after coronary artery bypass graft surgery with extracorporeal circulation Cytokine 2001, 13:314-316 10.1006/cyto.2000.0834 11243710
7. Denizot Y Guglielmi L Cornu E Nathan N Alterations in plasma angiogenic growth factor concentrations after coronary artery bypass graft surgery: relationships with post-operative complications Cytokine 2003, 24:7-12 10.1016/S1043-4666(03)00241-2 14561486
8. Burton PBJ Owen VJ Hafizi S Barton PJR Carr-White G Koh T De Souza A Yacoub MH Pepper JR Vascular endothelial growth factor release following coronary artery bypass surgery: Extracorporeal circulation versus "beating heart" surgery Eur Heart J 2000, 21:1708-1713 10.1053/ euhj.2000.2177 11032698
9. Cotton JM Mathur A Hong Y Brown AS Martin JF Erusalimsky JD Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery Eur Heart J 2002, 23:953-959 10.1053/euhj.2001.3034 12069450
10. Smith SK Angiogenesis, vascular endothelial growth factor and the endometrium Hum Reprod Update 1998, 4:509-519 10.1093/humupd/4.5.509 10027603
11. Norrby K Mast cells and angiogenesis APMIS 2002, 110:355-371 10.1034/ j.1600-0463.2002.100501.x 12076253
12. Neufeld G Cohen T Gengrinovitch S Poltorak Z Vascular endothelial growth factor (VEGF) and its receptors FASEB J 1999, 13:9-22 9872925
13. Kendall RL Wang G Thomas KA Identification of a natural soluble form of the vascular endothelium growth factor receptor, FLT-1, and its heterodimerisation with KDR Biochem Biophys Res Commun 1996, 226:324-328 10.1006/bbrc.1996.1355 8806634
14. Denizot Y Leguyader A Cornu E Laskar M Orsel I Vincent C Nathan N Release of soluble vascular endothelial growth factor receptor-1 (sFlt-1) during coronary artery bypass surgery J Cardiothorac Surg 2007, 2:38 10.1186/1749-8090-2-38 17888151 2034558
15. Murray JF Matthay Ma Luce JM Flick M An expanded definition of the acute respiratory distress syndrome Am Rev Respir Dis 1988, 138:720-723 3202424
16. Roth-Isigkeit A Borstel TV Seyfarth M Schmucker P Perioperative serum levels of tumor-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution Clin Exp Immunol 1999, 118:242-246 1905422 10540185 10.1046/ j.1365-2249.1999.01050.x
17. Barleon B Reusch P Totzke F Herzog C Keck C Martiny-Baron G Marmé D Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors Angiogenesis 2001, 4:143-154 10.1023/A:1012245307884 11806246
18. Van der Linden PJ Hardy JF Daper A Trenchant A De Hert SG Cardiac surgery with cardiopulmonary bypass: Does aprotinin affect outcome? Br J Anaesth 2007, 99:646-652 10.1093/bja/aem252 17855736
19. Börgermann J Scheubel RJ Simm A Silber RE Friedrich I Inflammatory response in on-versus off-pump myocardial revascularization: Is ECC really the culprit? Thorac Cardiovasc Surg 2007, 55:473-480 10.1055/ s-2007-965631 18027331
20. Cheng DC Bainbridge D Martin JE Novick RJ evidence-based perioperative clinical outcomes research group Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials Anesthesiology 2005, 102:188-203 10.1097/00000542-200501000-00028 15618803
21. Chung NAY Lydakis C Belgore F Blann AD Lip GYH Angiogenesis in myocardial infarction. An acute or chronic process? Eur Heart J 2002, 23:1604-1608 10.1053/euhj.2002.3312 12323160
22. Chung NA Lydakis C Belgore F Li-Saw-Hee FL Blann AD Lip GYH Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease Heart 2003, 89:1411-1415 1767979 14617549 10.1136/heart.89.12.1411
23. Yano K Liaw PC Mullington JM Shih SC Okada H Bodyak N Kang PM Toltl L Belikoff B Buras J Simms BT Mizgerd JP Carmeliet P Karumanchi SA Aird WC Vacular endothelial growth factor is an important determinant of sepsis morbidity and mortality J Exp Med 2006, 203:1447-1458 2118329 16702604 10.1084/jem.20060375
24. Hamade N Kuwano K Yamada M Hagimoto N Hiasa K Egashira K Nakashima N Maeyama T Yoshimi M Nakanishi Y Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice J Immunol 2005, 175:1224-1231 16002726
25. Miotla J Maciewicz R Kendrew J Feldmann M Paleolog E Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis Lab Invest 2000, 80:1195-1205 10950110